Aug 9, 2022 at 4:30 PM EDT
Keyword Search
- Summary ToggleInfinity to Participate in Wells Fargo and H.C. Wainwright Investor ConferencesAugust 31, 2022 at 7:00 AM EDT
- Summary ToggleInfinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateAugust 9, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment ConferenceMay 17, 2022 at 8:35 AM EDT
- Summary ToggleInfinity Pharmaceuticals Reports First Quarter 2022 Financial ResultsMay 3, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 8, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Company HighlightsMarch 29, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare ConferenceMarch 9, 2022 at 8:35 AM EST